Literature DB >> 12115075

Immunohistochemical expression of VEGF and VEGF receptors in nasal polyps as compared to normal turbinate mucosa.

Claus Wittekindt1, Alexander Hess, Wilhelm Bloch, Suleiman Sultanie, Olaf Michel.   

Abstract

The factors involved in the development of chronic inflammation and edema in nasal polyps remain to be clarified. The expression of vascular endothelial growth factor (VEGF) has been described in plasma cells, suggesting that plasma cells may play a major role in the development of edema in nasal polyps through the production of VEGF. We performed immunohistochemical analysis using specific antibodies to VEGF and to the known VEGF receptors, VEGFR-1 and VEGFR-2, on paraffin sections of human nasal polyps ( n=11) and controls of human mucosa of the normal middle turbinates ( n=6). In normal turbinate mucosa, sporadic immunostaining for VEGF was observed throughout the endothelial cells of the small veins and arteries. VEGFR-1 and VEGFR-2 expression was faint in the healthy turbinates. In nasal polyp tissues, strong immunostaining for VEGF was found in the endothelium of blood vessels and in the infiltrating perivascular inflammatory cells. Fibroblasts also stained for VEGF. Strong immunolabeling to VEGFR-1 was evident in the vascular endothelium, whereas weak to moderate VEGFR-1-staining was generally confined to scattered mononuclear round cells. Mononuclear round cells and the endothelium of capillaries revealed immunoreactivity to VEGFR-2. These findings support a role for VEGF and its receptors, VEGFR-1 and VEGFR-2, in the development and perpetuation of edema and angiogenesis in nasal polyps.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115075     DOI: 10.1007/s00405-002-0467-9

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  13 in total

1.  Angiogenesis in chronic rhinosinusitis with nasal polyps and in antrochoanal polyps.

Authors:  Nir Hirshoren; Tzahi Neuman; Menachem Gross; Ron Eliashar
Journal:  Inflamm Res       Date:  2010-10-23       Impact factor: 4.575

2.  Endoglin (CD105) expression in sinonasal polyposis.

Authors:  Giancarlo Ottaviano; Rocco Cappellesso; Ioannis Mylonakis; Marco Lionello; Niccolò Favaretto; Luciano Giacomelli; Cristiano Spoladore; Rosario Marchese-Ragona; Filippo Marino; Alberto Staffieri; Alessandro Martini; Gino Marioni
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-06       Impact factor: 2.503

3.  Surgical treatment for nasal polyposis: predictors of outcome.

Authors:  Marko Velimir Grgić; Hrvoje Ćupić; Livije Kalogjera; Tomislav Baudoin
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-30       Impact factor: 2.503

4.  The effect of corticosteroid therapy on cyclooxygenase 2, vascular endothelial growth factor, and inducible nitric oxide synthase expression levels in nasal polyposis.

Authors:  Demet Yazici; Ülkü Tuncer; Aysun Uğuz
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06       Impact factor: 2.503

5.  Endothelial nitric oxide synthase/soluble guanylate cyclase system in human nasal polyps.

Authors:  Paloma Escobar; Francisco J Márquez; Carolina Carrasco; Sergio Alonso-Orgaz; José Fortes; Carlos Cenjor; Antonio López-Farré
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-11-18       Impact factor: 2.503

Review 6.  Gene expression signatures: a new approach to understanding the pathophysiology of chronic rhinosinusitis.

Authors:  Chunwei Li; Li Shi; Yan Yan; Bruce R Gordon; William M Gordon; De-Yun Wang
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

7.  Basic fibroblast growth factor expression in recurrent versus non-recurrent nasal polyposis.

Authors:  Per Cayé-Thomasen; Knud Larsen; Peter Tingsgaard; Mirko Tos
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-09       Impact factor: 2.503

8.  Vascular endothelial growth factor drives autocrine epithelial cell proliferation and survival in chronic rhinosinusitis with nasal polyposis.

Authors:  Hyun Sil Lee; Allen Myers; Jean Kim
Journal:  Am J Respir Crit Care Med       Date:  2009-09-17       Impact factor: 21.405

Review 9.  Pathogenesis of nasal polyps: an update.

Authors:  Rafal Pawliczak; Anna Lewandowska-Polak; Marek L Kowalski
Journal:  Curr Allergy Asthma Rep       Date:  2005-11       Impact factor: 4.919

10.  Increased Tissue Expression of Lectin-Like Oxidized LDL Receptor-1 (LOX-1) Is Associated with Disease Severity in Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Manabu Nishida; Sachio Takeno; Kohta Takemoto; Daisuke Takahara; Takao Hamamoto; Takashi Ishino; Tomohiro Kawasumi
Journal:  Diagnostics (Basel)       Date:  2020-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.